Semaglutide: the oral comparison point Semaglutide is the only GLP-1 receptor agonist with an FDA-approved oral formulation (Rybelsus)
As a reminder, SELECT enrolled 17,604 adults who were 45 years or older, overweight or obese, without diabetes and had a diagnosis of cardiovascular disease, including prior myocardial infarction, stroke, and/or peripheral artery disease
Bloating or Discomfort Backed-up food and waste in the gastrointestinal tract can lead to bloating, abdominal distension, and discomfort in people experiencing constipation during Ozempic therapy
They will get worse
The specialists at Primary Care of Clear Lake can guide patients on how to maximize the benefits of semaglutide, offering support and advice on diet and exercise to help patients achieve their weight loss goals effectively and sustainably
If youre on a government-funded plan, youll need to check other options like coverage appeals, state Medicaid criteria, or non-profit co-pay assistance programs if available